Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
08/2005
08/17/2005CN1654066A Kidney-nourishing yang-strengthening medicine
08/17/2005CN1654065A Oral administered agent with milk secretion promoting function
08/17/2005CN1215069C Sulfonamicles and derivatives thereof that moulate the activity of endothelin
08/17/2005CN1214806C Plant type composite sterilant used for mice
08/17/2005CN1214795C Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism
08/17/2005CN1214786C New use of modafinil and D/L enantiomer
08/17/2005CN1214784C Quick-releasing tablet in vagina and its preparing method
08/16/2005US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders
08/16/2005US6930100 Phosphate prodrugs of fluoroxindoles
08/16/2005CA2098533C Carrier system against gnrh
08/11/2005US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders
08/11/2005US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis
08/11/2005US20050176814 mono- or polydeuterated 4-(p-Methylsulfonylphenyl]-3-phenyl-2-(5H)-furanones; degenerative joint disorders, acute pain and primary dysmenorrhea
08/11/2005US20050176803 Indole derivatives as anti-inflammatory agents
08/11/2005US20050176800 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid
08/11/2005US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
08/11/2005US20050176759 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disorders
08/11/2005US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted
08/11/2005US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation
08/11/2005US20050176709 Selective NPY (Y5) antagonists
08/11/2005US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity
08/11/2005US20050176700 (2-methoxyphenyl)acetic acid-7-{4-[3-(2-methoxybenzyloxy)-propoxy]phenyl}-3-(2-thiophen-2-ylacetyl)-3,9-diazabicyclo[3.3.1]non-6-en-6-yl-methyl ester; metabolically stable, orally bioavailable and sufficiently soluble; industrial scale; non-peptidic nature, low molecular weight
08/11/2005US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity
08/11/2005US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs
08/11/2005US20050176632 Angiogenesis inhibitors
08/11/2005US20050176123 Protease inhibitor
08/11/2005US20050175722 Extracts of Tribulus terrestris, Epimedium koreanum, Cinnamon cassia, arginine, and carrier/excipient
08/11/2005US20050175713 Bismuth subnitrate in gel of aluminum stearate for sealing teat canal; mastitis
08/11/2005US20050175639 Methods
08/10/2005EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
08/10/2005EP1451166B1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
08/10/2005EP1399406B1 Novel estrogen receptor ligands and methods i
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/10/2005EP1157002B1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
08/10/2005EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
08/10/2005CN2715753Y Combined transdermal cream for treating male impotence and premature ejaculation
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653068A Novel diazabicyclic biaryl derivatives
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1653042A Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
08/10/2005CN1653036A Amino acids with affinity for the alpha-2-delta-protein
08/10/2005CN1652845A Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
08/10/2005CN1652820A Methods of treatment using CTLA-4 antibodies
08/10/2005CN1652807A Formulations useful in the treatment of male and female impotence
08/10/2005CN1652806A Formulations useful in the treatment of male and female impotence
08/10/2005CN1652799A Sulfatase inhibiting progestogen-only contraceptive regimens
08/10/2005CN1652798A Continuous sulfatase inhibiting progestogen hormone replacement therapy
08/10/2005CN1652797A Sulfatase inhibiting continuous progestogen contraceptive regimens
08/10/2005CN1652796A Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
08/10/2005CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators
08/10/2005CN1652779A Treatment of chemokine mediated diseases
08/10/2005CN1652769A Phosphate prodrugs of fluorooxindoles
08/10/2005CN1652768A 5-(2-hydroxy-3-'1-(3-trifluoromethylphenyl)-cyclopropl-propionylamino)-phtalide and related compounds with progesterone receptor modulating activity for use in fertility control and hormone replaceme
08/10/2005CN1651432A Method of refining plamatine from herba fibranreae recisae total ulkuloid and its application
08/10/2005CN1651091A Sodium alginate microglobule blood vessel suppositery containing gynecoiatry medicine and its preparation method
08/10/2005CN1651087A Combination of organic compounds
08/10/2005CN1651074A Use of neurotoxin therapy for treatment of urologic and related disorders
08/10/2005CN1651073A Rat acarpous medicine and its preparation method
08/10/2005CN1651068A Oral liquid for treating habitual abartion and its dispensing method
08/10/2005CN1651057A Cinnamon poria capsule and its preparation process
08/10/2005CN1651056A Cinnamon poria capsule and its preparation process
08/10/2005CN1651040A Preparation method of Fuyankang medicine for treating gynecopathy
08/10/2005CN1651033A Chinese medicinal composition for treating gynecopathy
08/10/2005CN1651023A Mammary proclivity elimination capsule and its preparation provess
08/10/2005CN1651019A Four ingredient soft capsule and its preparation process
08/10/2005CN1651004A Compound ginseng tea preparation for treating chronic pelvic cavity inflammation and its preparation method
08/10/2005CN1650997A Chinese medicinal gel for killing sperm in vagina and its preparation method
08/10/2005CN1650980A Preparation of medicine using formula containing angelicae sinensis radix etc. for treating gynecopathy algomenorrhea
08/10/2005CN1650975A Preparation method of compound peach blossom deea tortoise life nourishing agent
08/10/2005CN1650961A Baofukang vagina film agent and its making method
08/10/2005CN1650960A Baofukang vagina effervescent tablet and its making method
08/10/2005CN1650950A Traditional Chinese medicine for treating cow endo metritis
08/10/2005CN1650935A Traditional Chinese medicine for treating female barrenness due to atresia of oviduct
08/10/2005CN1650934A Traditional Chinese medicine for treating female barrenness due to atresia of oviduct
08/10/2005CN1650928A Gynecoiatry leukorrhea stopping capsule and its preparation technology
08/10/2005CN1650922A Chinese medicinal composition for treating blood depletion qi vacuity, menstral irregularity and its preparation method
08/10/2005CN1650909A Medicine for controlling cattle breed sex
08/10/2005CN1650907A Zhogkang pill
08/10/2005CN1650888A Povidone-iodine suppository for treating dairy cattle endometritis
08/10/2005CN1650872A Externally used medicine for treating sexual dysfunction
08/10/2005CN1650860A Econazole film agent and its preparation method
08/10/2005CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
08/10/2005CN1213761C Aloe lotion and its preparing method
08/10/2005CN1213755C Use of exemestane in preparing medicinal composition for first-line treatment of breast cancer
08/10/2005CN1213754C Beta-carboline pharmaceutical compositions
08/09/2005US6927317 Modulating ramp activity
08/09/2005US6927224 Anticancer agents; osteoporosis
08/09/2005US6926898 Albumin fusion proteins
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/04/2005WO2005070449A1 Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
08/04/2005WO2005007150A3 Method for inhibiting protein synthesis in sperm
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders
08/04/2005US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/04/2005US20050171186 3-(1',2'-Dihydro-2'-thioxospiro[cyclohexane-1,3'-[3H]indol]-5'-yl)benzonitrile; 5'-(5-Cyano-1-methyl-1H-pyrrol-2-yl)spiro[cyclohexane-1,3'-[3H]indol]-2'-ylidenecyanamide; progesterone receptor agonist; mixture with estrone (estrogen); hormone replacement therapy, contraception; anticarcinogenic
08/04/2005US20050171178 Exo-1-methyl-1H-imidazole-4-sulfonic acid {3-[6-ethyl-3-(2-hydroxy-indan-2-ylmethyl)-3-aza-bicyclo[3.1.0]hex-6-yl]-phenyl}-amide; opioid receptors (mu, kappa and delta) antagonists; not substrate of the variable enzyme CYP2D6; addiction to an opiates, alcohol; obesity
08/04/2005US20050171158 1-(sulfonylaminomethylcarbonyl)-4-cyclohexylpiperidine compounds such as N-[1-(R)-(4-chlorobenzyl)-2-(4-cyclohexyl-4-[1,2,4]triazol-1-ylmethyl-piperidin-1-yl)-2-oxo-ethyl]-methanesulfonamide; various diseases and disorders such as weight control, eating disorders
08/04/2005US20050171129 Polycyclic guanine derivative phosphodiesterase V inhibitors
08/04/2005US20050171122 Mitotic kinesin inhibitors
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
1 ... 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 ... 557